At the University of Osaka, researchers have cracked a genetic puzzle that could transform how doctors diagnose one of oral cancer's most elusive forms. Carcinoma cuniculatum—a rare variant of oral squamous cell carcinoma that grows in slow, burrowing patterns—has long confounded even specialist pathologists, masquerading as harmless gum disease or infection. Now, a genetic fingerprint has emerged that could change that, offering the promise of earlier, clearer diagnosis for patients facing this overlooked condition.
The challenge is real and urgent. Oral squamous cell carcinoma, the most common type of oral cancer, can be difficult to identify when it mimics benign lesions, and delays in diagnosis allow cancer to advance. But carcinoma cuniculatum is particularly deceptive. It grows slowly and rarely spreads, which usually means a good prognosis—yet this same slow growth and benign appearance make it a "wolf in sheep's clothing," in the words of Katsutoshi Hirose, corresponding author of the study published in Head and Neck Pathology. The paradox is that a cancer with better biological behavior can be harder to catch because it doesn't look like what specialists expect to see.
To uncover the genetic truth, Hirose and his team at Osaka conducted an ambitious analysis, reviewing 2,002 oral cancer cases from pathology archives across multiple institutions. From that large dataset, they identified just 23 cases with the telltale burrowing growth pattern of carcinoma cuniculatum—a rarity within a rarity. What they found was striking: 87.5% of those 23 cases carried pathogenic genetic alterations that set them apart from conventional oral cancers.
The genetic signature tells a revealing story. While carcinoma cuniculatum shows fewer alterations in the major oral cancer driver genes TP53 and CDKN2A—genes that are often mutated in aggressive forms of the disease—it displays more frequent alterations in other genes: FAT1, NOTCH1, PIK3CA, and CASP8. This distinct pattern appears to explain why carcinoma cuniculatum behaves so differently, growing more slowly and with a lower risk of spread. The genes that drive rapid, aggressive cancer are less active; the genes that shape this disease's particular biology are more active.
First author Sawako Ono sees the clinical potential clearly: genetic testing could become a practical tool for accurate diagnosis and targeted treatment, helping clinicians identify the condition more reliably and improve patient care. Rather than relying on appearance alone—a method that even pathologists find unreliable for carcinoma cuniculatum—doctors could order a genetic test and get an answer. For a cancer that is, by definition, hard to recognize, that answer could arrive months earlier than it otherwise would.
The significance extends beyond carcinoma cuniculatum itself. This research demonstrates a principle: when a cancer looks different and behaves differently, its genetics often tells why. By uncovering gene alterations in one rare form of oral cancer, these researchers have shown how genetic testing could illuminate other difficult-to-diagnose cancers. For the patients facing this rare, overlooked condition, the findings offer real hope—the chance to move from uncertainty and delayed treatment to clarity and speed.